Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool March 22, 2010 Brian Orelli	Health-Care Reform Passes! Here's Where to Invest Now Some healthy suggestions for your portfolio.
The Motley Fool January 28, 2010 Brian Orelli	Health-Care Reform Is Dead. Probably. Breaking up the bill doesn't seem like the answer. What do insurers and pharmaceutical companies have to say?
The Motley Fool July 31, 2009 Brian Orelli	A Health-Care Investor's Nightmare When it comes to health-care reform, no news is not good news; the House's recent plan to delay voting on a health-care reform bill until September should have investors reaching for the antacids.
The Motley Fool September 18, 2008 Brian Orelli	Medical Device Makers Throwing Money Down the Tube Congress is investigating medical device makers' direct-to-consumer ads.
The Motley Fool January 26, 2011 Brian Orelli	Health-Care Reform Lives: Here's Where to Invest State of the Union turned investment thesis regarding health insurance companies.
The Motley Fool February 9, 2010 Brian Orelli	What Bipartisan Health-Care Reform Means for Investors Republicans and Democrats will debate on TV, but little may come of it.
The Motley Fool September 17, 2009 Brian Orelli	Baucuscare: Who's Paying? You are -- indirectly, of course. But nobody said reform would be cheap.
The Motley Fool November 2, 2009 Brian Orelli	Winners and Losers of the House Health-Care Reform Bill There's something for everyone to hate.
The Motley Fool April 22, 2009 Selena Maranjian	Will Health-Care Reform Hurt Investors? The bad news here is that there's quite a bit of uncertainty around this issue, and that some health-care-focused companies may end up suffering. Read on to see who.
BusinessWeek May 20, 2009 Maria Bartiromo	Pfizer's Kindler on Health-Care Reform and the Wyeth Deal Pfizer's CEO discusses its acquisition of Wyeth and its plan to provide some drugs for free to those without jobs and insurance.
The Motley Fool January 14, 2010 Jim Mueller	Roundtable: Which Health-Care Stocks to Buy Now Three Fool analysts give you their best ideas on where to put your money after the health-care reform bill makes it out of Congress.
The Motley Fool March 12, 2010 Brian Orelli	Insurers to Washington: We're Not the Problem Insurers say they're a small piece of the problem pie.
The Motley Fool February 26, 2010 Brian Orelli	Political Theater: More Entertaining Than Helpful Health-care reform, like health-care stocks, remains still stuck in limbo.
The Motley Fool November 30, 2009 Brian Orelli	The Real Problem With the Public Health-Care Plan The passing of a public plan probably won't affect the companies you invest in all that much, but there's certainly the possibility that a public plan could change into something that could do a lot more damage.
BusinessWeek March 24, 2010 Nussbaum et al.	Obamacare's Cost Scalpel How does the health-care overhaul propose to control spending? By evaluating treatments through "comparative effectiveness research"
BusinessWeek October 22, 2009 Sasseen & Arnst	Who Picks Up the Tab for Health Reform Insurers and taxpayers are likely to pay big chunks of the $900 billion bill to overhaul the nation's health-care system. Doctors will feel the least pain.
The Motley Fool December 24, 2009 Brian Orelli	Health-Care Reform: Two-Thirds Finished The U.S. Senate voted this morning to pass the health-care reform bill, moving us closer to capping off the long process that's weighed on health-care and insurance stocks this year.
The Motley Fool November 7, 2008 Brian Orelli	Will Obama Make Your Portfolio Healthy? The changes coming in the health-care industry could be a mixed bag of good and bad for your portfolio.
The Motley Fool September 9, 2009 Brian Orelli	Don't Like High Drug Costs? Blame Canada. Through a combination of price controls instituted by the Patented Medicine Prices Review Board, and through government negotiations, Canada is able to keep its drug costs down for its citizens. But that doesn't make it right.
BusinessWeek March 25, 2010 Charlie Rose	Aetna's Ron Williams on Health Care: What to Expect What does this new mandate mean for individuals, companies, and the health-care industry?
The Motley Fool March 25, 2009 Brian Orelli	You Can't Have One Without the Other Heath insurers are playing fair.
The Motley Fool September 25, 2008 Brian Lawler	Eli Lilly's Dose of Disclosure The pharmaceutical pledges public reports of its dealings with doctors.
The Motley Fool February 25, 2010 Brian Orelli	An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies.
The Motley Fool May 25, 2010 Brian Orelli	GE's Looking Healthy and Imaginative Happy 1-year birthday, Healthymagination. GE is also focused on saving itself some money through decreased health-care costs.
The Motley Fool December 23, 2009 Brian Orelli	2009 Cheers and Jeers for Pharma Unfortunately, it was more of the latter.
BusinessWeek September 16, 2009 Catherine Arnst	The Truth About Malpractice Lawsuits President Barack Obama tapped into a large vein of public support when he suggested recently that he is open to reforming medical malpractice laws.
The Motley Fool February 27, 2009 Brian Orelli	Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas.
CFO Kris Frieswick	Clinical Trials A new kind of pricing pressure puts pharmaceutical CFOs in an unfamiliar role: evangelist...
The Motley Fool December 3, 2009 Brian Orelli	Health-Care Reform Is Very Taxing On the industries that keep us alive.
The Motley Fool February 12, 2009 Brian Orelli	Stimulus Could Be Bitter Pill for Some Investors Health-care shareholders need to watch provisions of the stimulus bill closely.
The Motley Fool August 28, 2009	Roundtable: Will Health-Care Reform Kill Capitalism? Motley Fool analysts give their opinions on the health-care reform debate.
The Motley Fool November 20, 2009 Kris Eddy	Drug Companies Targeted, Again Is a review of drug prices by Congress something to worry about?
The Motley Fool April 6, 2009 Michael P. Cecil	Investing in Pharma? Remember Rule No. 1 Health care reform is likely this year. How will that affect your pharma investments?
The Motley Fool November 20, 2008 Brian Orelli	Like Coupons, Only Better Companies that provide medical products and services and are lowering their costs should do well in this environment.
The Motley Fool May 18, 2010 Brian Orelli	Price Inflation in Check? Not in This Industry. Drug prices are on the rise. For now.
The Motley Fool February 26, 2009 Brian Orelli	Obama's Uncertainty Is Unhealthy for Investors There was lots of talk about health care reform in the President's speech before Congress and the nation, but investors are still in a wait-and-see mode.
The Motley Fool September 28, 2009 Brian Orelli	Health-Care Reform: Pocketbook or Portfolio? Motley Fool analysts and readers weigh in on the topic of health-care reform.
The Motley Fool September 10, 2009 Brian Orelli	Obamacare: Something for Everyone to Hate Health insurers saw more to love, though.
The Motley Fool September 30, 2009 Dave Mock	Health-Care Stocks Obama Would Buy This up-and-coming sector could play a big role in reform, especially for companies that bring new efficiencies to health care.
Pharmaceutical Executive October 1, 2008 Walter Armstrong	The Drug Vote '08 A head-to-head comparison of the Drug Vote '08
The Motley Fool December 30, 2010 Brian Orelli	This NICE Deal Could Foreshadow 2011 Value-based pricing is coming. The only way to encourage lower drug costs is to get the end user to pay the cost directly.
The Motley Fool January 28, 2011 Brian Orelli	Avoid This Falling Knife for Now 2011 could be just the start of a long slide for Lilly. And 2012 will see difficult year-over-year comparison.
The Motley Fool September 17, 2009 Charly Travers	Companies That Will Thrive Under Obamacare They are out there.
The Motley Fool February 3, 2011 Brian Orelli	Get Ready for Merck's Bumpy Ride Long-term earnings guidance gets thrown out the window.
The Motley Fool September 23, 2004 Rich Smith	Insurers vs. Big Pharma The debate over pill-splitting has gone on for some time and will continue to have an effect on the stock prices of whichever side is winning in any given quarter, be it Big Pharma or big insurance and its generic drug allies.
The Motley Fool January 20, 2010 Brian Orelli	Health-Care Reform: It's Not Over Yet Massachusetts has spoken with its election of Scott Brown to the Senate. What's up next?
The Motley Fool August 26, 2010 Brian Orelli	Drug Prices Up, but Don't Read Too Much Into It AARP is out with its annual report on the cost of medications, and it's more of the same: bad news if you're a consumer, but good news if you're invested in drugmakers.
The Motley Fool May 20, 2008 Brian Orelli	Is Google's Newest Offering a Healthy Investment? Having all your medical records in one place is a good idea, but will people use Google Health?
BusinessWeek August 6, 2009	Health Reform: A Timeline The latest battle over how to overhaul the U.S. health-care system intensified last fall with the election of Barack Obama.
BusinessWeek October 1, 2009 Sasseen & Arnst	Why Business Fears the Public Option Executives contend that it will lead health-care providers to charge patients in private plans higher rates.